Reference : Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript ...
Scientific journals : Article
Life sciences : Veterinary medicine & animal health
Human health sciences : Immunology & infectious disease
Human health sciences : Laboratory medicine & medical technology
http://hdl.handle.net/2268/7622
Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny
English
Dehan, Pierre mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques >]
Couvreur, B. [> > > >]
Hamers, C. [> > > >]
Lewalle, P. [> > > >]
Thiry, Etienne mailto [Université de Liège - ULg > Département des maladies infectieuses et parasitaires > Virologie, épidémiologie et pathologie des maladies virales >]
Kerkhofs, P. [> > > >]
Pastoret, Paul-Pierre mailto [Université de Liège - ULg > Département des maladies infectieuses et parasitaires > Département des maladies infectieuses et parasitaires >]
21-Jul-2005
Vaccine
Elsevier Sci Ltd
23
33
4236-4246
Yes (verified by ORBi)
International
0264-410X
Oxford
[en] pestivirus ; vaccine ; bovine
[en] An infectious cDNA clone of the hypervirulent bovine viral diarrhoea virus (BVDV) strain 890 (isolate 256) was produced by a streamlined PCR procedure. As compared to the published sequence of strain 890, the nucleotide sequencing of cloned cDNA corresponding to isolate 256 revealed several mutations seven of which were attributed to the cloning procedure. The infectious transcript was transfected into permissive cells and led to viral multiplication (AvrII+ strain). In vitro, viral titres reached by the parental strain exceed those of the AvrII+ strain by more than one order of magnitude. The latter was clearly less virulent to young calves as indicated by clinical, haematological and virological parameters. Thirty-four days after inoculation with AvrII+ strain, calves were challenged with the virulent parental strain. The animals were protected as compared to unvaccinated controls. Therefore, our approach led to the production of an attenuated strain with potential use as a vaccine strain and will be useful for studies of virulence determinants in BVDV-2. (c) 2005 Elsevier Ltd. All rights reserved.
http://hdl.handle.net/2268/7622
10.1016/j.vaccine.2005.03.026

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
252pub_thiry.pdfAuthor postprint488.95 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.